Anavex Life Sciences Corp (AVXL)

[Lima4918]

I think it helps explain the timeline from first person dosed to today's announcement of a patient accepting the extension.

Of course I am assuming the first patient dosed went on for 7 weeks, then who knows if there was a wash period (but we do know from a patent issued with Cecchi as inventor that such a wash out period could be beneficial.

I think the patient is being treated the way Missling thinks is most effective, and I think that may include a wash out period.

Looks good to me, but I'm a biased long.